HealthMore in Health→
PSA screening appears to cut prostate cancer deaths modestly, updated review finds
An updated Cochrane review finds that PSA-based screening likely reduces prostate cancer deaths modestly, a change from the previous version of the evidence review.
Key Takeaways
- An updated Cochrane review says PSA screening likely reduces prostate cancer deaths.
- The review estimates about two fewer prostate cancer deaths per 1,000 men screened.
DE
DT Editorial Team··via medicalxpress.com